Mechanistic insights into a heterobifunctional degrader-induced PTPN2/N1 complex
PTPN2 (protein tyrosine phosphatase non-receptor type 2, or TC-PTP) and PTPN1 are attractive immuno-oncology targets, with the deletion of Ptpn1 and Ptpn2 improving response to immunotherapy in disease models. Targeted protein degradation has emerged as a promising approach to drug challenging targets including phosphatases. We developed potent PTPN2/N1 dual heterobifunctional degraders (Cmpd-1 and Cmpd-2) which facilitate efficient complex assembly with E3 ubiquitin ligase CRL4<sup>CRBN</sup>, and mediate potent PTPN2/N1 degradation in cells and mice. To provide mechanistic insights into the cooperative complex formation introduced by degraders, we employed a combination of structural approaches. Our crystal structure reveals how PTPN2 is recognized by the tri-substituted thiophene moiety of the degrader. We further determined a high-resolution structure of DDB1-CRBN/Cmpd-1/PTPN2 using single-particle cryo-electron microscopy (cryo-EM). This structure reveals that the degrader induces proximity between CRBN and PTPN2, albeit the large conformational heterogeneity of this ternary complex. The molecular dynamic (MD)-simulations constructed based on the cryo-EM structure exhibited a large rigid body movement of PTPN2 and illustrated the dynamic interactions between PTPN2 and CRBN. Together, our study demonstrates the development of PTPN2/N1 heterobifunctional degraders with potential applications in cancer immunotherapy. Furthermore, the developed structural workflow could help to understand the dynamic nature of degrader-induced cooperative ternary complexes.
Authors
- Eunice Park (ORCID: https://orcid.org/0000-0003-1159-2374)
- Chaohong Sun (ORCID: https://orcid.org/0000-0003-2314-3197)
- Mark E. Fitzgerald (ORCID: https://orcid.org/0009-0001-9449-7892)
- Amirhossein Mafi (ORCID: https://orcid.org/0000-0002-8366-6785)
- Christopher G. Nasveschuk (ORCID: https://orcid.org/0000-0003-4671-6939)
- Marcia N. Paddock (ORCID: https://orcid.org/0000-0002-8350-1593)
- Kelly L. Klinge
- James A. Henderson (ORCID: https://orcid.org/0000-0001-6278-9973)
- Matthew Bratkowski (ORCID: https://orcid.org/0000-0003-3911-0533)
- Gesine K. Veits
- Vincent S. Stoll
- Wei Qiu (ORCID: https://orcid.org/0000-0002-5548-5629)
- Stewart L. Fisher (ORCID: https://orcid.org/0009-0005-5167-5213)
- Giovanna Scapin (ORCID: https://orcid.org/0000-0002-0724-2286)
- Keith M. Hamel (ORCID: https://orcid.org/0000-0003-1559-8431)
- Qi Hao
- Claudio Catalano (ORCID: https://orcid.org/0000-0002-2437-6235)
- Dan Eaton (ORCID: https://orcid.org/0000-0003-3933-0958)
- Kenton L. Longenecker
- David Stokoe (ORCID: https://orcid.org/0000-0002-6333-5364)
- Michael E. Kort (ORCID: https://orcid.org/0000-0003-3059-9790)
- Harit U. Vora
- Qi Sun (ORCID: https://orcid.org/0009-0003-5107-1909)
- Ping Li (ORCID: https://orcid.org/0000-0002-3314-943X)
- Manoj K Rathinaswamy (ORCID: https://orcid.org/0000-0001-5909-4353)
- Rinku Jain (ORCID: https://orcid.org/0000-0003-2285-7809)
- Christina K. Baumgartner (ORCID: https://orcid.org/0000-0002-6872-6209)
- Alexander W. Hird
- Charles W. Hutchins
Institutions
- California State University, San Marcos (US)
- AbbVie (United States) (US)
- ISCO International (United States) (US)
- C4 Therapeutics (United States) (US)
Publication Details
- Journal
- Communications Chemistry
- Published
- 2024-08-16
- DOI
- https://doi.org/10.1038/s42004-024-01263-7
- Citations
- 7
- Primary Topic
- Protein Tyrosine Phosphatases
- Type
- article
- Field-Weighted Citation Impact
- 1.64
Funders
- U.S. Department of Energy
- University of Victoria
- Industrial Macromolecular Crystallography Association Collaborative Access Team
- Genome British Columbia
- Office of Science
- Basic Energy Sciences